Upcoming events

CTO (Chronic total occlusion)

Here you will find all the latest content on chronic total occlusion (CTO) published on this website. Results are listed in chronological order.

Recently we have seen an increase in successful percutaneous coronary interventions (PCI) of CTO in part due to improvements in hardware (guidewires and balloons), the introduction of dedicated devices (microcatheters, channel dilators, dissection-reentry devices) and the elaboration of CTO-specific techniques. To fully grasp CTO today, here you will find here everything that you need to know including the latest devices and techniques as well as advances in imaging, the use of adjunctive pharmacotherapy, vascular access or understanding bleeding risks…

Filtered By

185 results

EuroCTO: What is the best option for treating CTO: PCI or optimal medical therapy?

From EUROPCR 2017

Which approach best improves clinical symptoms? Join G. Werner as he reviews this randomized trial whose goal was the assessment of these two strategies and their impact on the overall health of patients at 12 months. Learn of the specificities of this trial including how patients with multivessel disease were included in both arms, as well as the efficacy of either treatment or the number of crossovers after intention-to-treat was decided upon. Finally, which approach proved to be more successful in improving angina frequency or quality of life? Learn more here.

EuroPCR 2017: EuroCTO trial: better quality of life for patients with CTO PCI compared with OMT

EuroPCR 2017 Highlights: Coronary Interventions

20 May 2017 - From EUROPCR 2017

From the standpoint of 40 years of angioplasty, 20 years of physiological assessment and emerging data on a variety of topics, J. Byrne and T. Johnson review data published at EuroPCR 2017. Interest remains intense concerning bioresorbable stents (BRS) with ongoing international trials and whether evolving new devices and techniques will answer the problem of thrombosis. Complex interventions such as CTO showed interesting data and the evolution in our use of iFR or FFR continues to demonstrate the role innovation plays in our specialty, hereby better understanding physiology to improve treatment strategies and positively impacting outcome.

CTO, innovative approaches

19 May 2017

Frequent treatment dilemmas in coronary interventions

19 May 2017

EuroPCR 2017: Fresh data on OCT management, FFR guidance and bioresorbable stents

Participants saw exciting results from a number of late-breaking trials during EuroPCR 2017, focusing on such topics as chronic total occlusions (CTO), neurological outcomes following TAVI in intermediate-risk patients, and bioresorbable vs. bare metal stents.

Serbia and Siberia share their most educational cases: CTO PCI: teaching points from challenging cases in everyday practice

18 May 2017

CTO, challenging cases

18 May 2017

AICT and APSIC@EuroPCR: challenging learning cases of endovascular interventions in Asia-Pacific region

18 May 2017

An image is worth 1,000 words

18 May 2017